Ovid Therapeutics (OVID) EBT (2016 - 2026)
Ovid Therapeutics (OVID) reported EBT of -$17.0 million for Q1 2026, down 65.98% on a YoY basis from -$49.9 million in Q1 2025, and down 275.8% quarter-over-quarter from $9.7 million in Q4 2025.
Ovid Therapeutics (OVID) EBT (2016 - 2026) Analysis & Trends
Ovid Therapeutics has reported EBT for 11 years, with the latest figure at -$17.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 65.98% year-over-year to -$17.0 million; the trailing twelve-month figure through Mar 2026 stood at -$24.2 million (up 3.23% YoY), and the FY2025 full-year result was -$17.4 million, up 34.12% from the prior year.
- EBT for Q1 2026 stood at -$17.0 million, down from $9.7 million in the prior quarter.
- The five-year high for EBT was $9.7 million in Q4 2025, with the low at -$17.0 million in Q1 2026.
- Historically, EBT has averaged -$9.8 million across 5 years, with a median of -$12.0 million in 2022.
- The largest YoY upside for EBT was 204.43% in 2025 against a maximum downside of 154.97% in 2025.
- Ovid Therapeutics' EBT stood at -$11.5 million in 2022, then sank by 33.18% to -$15.3 million in 2023, then soared by 39.61% to -$9.3 million in 2024, then soared by 204.43% to $9.7 million in 2025, then slumped by 275.8% to -$17.0 million in 2026.
- The last three EBT figures came in at -$17.0 million (Q1 2026), $9.7 million (Q4 2025), and -$12.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | -16.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.99 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | -12.16 Mn |
| Jun 30, 2025 | -4.68 Mn |
| Mar 31, 2025 | -10.24 Mn |
| Dec 31, 2024 | -9.25 Mn |
| Sep 30, 2024 | -14.01 Mn |
| Jun 30, 2024 | 8.52 Mn |
| Mar 31, 2024 | -11.69 Mn |
| Dec 31, 2023 | -15.32 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -12.41 Mn |
| Mar 31, 2023 | -13.36 Mn |
| Dec 31, 2022 | -11.50 Mn |
| Sep 30, 2022 | -11.97 Mn |
| Jun 30, 2022 | -14.59 Mn |
| Mar 31, 2022 | -16.06 Mn |
| Dec 31, 2021 | -26.35 Mn |
| Sep 30, 2021 | -11.68 Mn |
| Jun 30, 2021 | -14.32 Mn |